PLIANT THERAPEUTICS INC. - COMMON STOCK

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results

08 8月 2022 15:05:02 条件 Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in BTIG Biotechnology Conference

02 8月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Primary Sclerosing Cholangitis

21 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

15 7月 2022 15:03:00 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Pricing of Upsized $200.0 Million Public Offering

12 7月 2022 18:46:28 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Proposed Public Offering of Common Stock

11 7月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Positive Safety and Efficacy Data from Phase 2a INTEGRIS-IPF Clinical Trial of PLN-74809 in Patients with Idiopathic Pulmonary Fibrosis

10 7月 2022 17:10:21 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Presentations at the International Liver Congress™ 2022 Highlighting Preclinical and Clinical Data in Support of the INTEGRIS-PSC Phase 2a Clinical Trial

24 6月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Presents Preclinical Data Highlighting A Novel Approach for the Treatment of Muscular Dystrophies

22 6月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Advancement of Integrin Target in Fibrosis Under Strategic Collaboration

16 6月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Presentations at the International Liver Congress™ 2022

15 6月 2022 15:01:00 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Presentations at 2022 American Thoracic Society International Conference

18 5月 2022 10:15:00 条件 Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Upcoming Investor Conferences

11 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

09 5月 2022 15:05:01 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Enters into $100 million Loan Facility Agreement with Oxford Finance to Support Ongoing Development of PLN-74809

05 5月 2022 07:00:03 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Idiopathic Pulmonary Fibrosis

03 5月 2022 07:00:02 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Announces Multiple Presentations at the 2022 American Thoracic Society International Conference

02 5月 2022 07:00:03 条件 Nasdaq GlobeNewswire

Pliant Therapeutics to Participate in Needham Healthcare Conference

05 4月 2022 07:03:00 条件 Nasdaq GlobeNewswire

CORRECTION - Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

28 2月 2022 18:43:43 条件 Nasdaq GlobeNewswire

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

28 2月 2022 15:05:00 条件 Nasdaq GlobeNewswire